Bliss GVS Pharma: Anupam Rasayan acquires control, 3 directors appointed

Bliss GVS Pharma Ltd announced a significant change in control following the acquisition of 47.95% equity shares by Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited. This transaction, completed on September 28, 2026, makes Anupam Rasayan and Mates Visa the new promoters. Concurrently, the board approved the appointment of three new Non-Executive Non-Independent Directors: Mr. Hetul Krishnakant Mehta, Mr. Amar Dilip Shah, and Mr. Pramod Badrinarayan Kasat. The company also noted the resignation of Mr. Narsimha Shibroor Kamath as Managing Director.